Cholangiocarcinoma with respect to IgG4 Reaction

International Journal of Hepatology

Volumn 2014, Issue , 2014, Pages

  Harada, Kenichi ^a   Nakanuma, Yasuni ^a,b  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^b SHIZUOKA CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G4;

ANTIGEN PRESENTING CELL; BILE DUCT CARCINOMA; BILIARY TRACT CANCER; CARCINOGENESIS; DIFFERENTIAL DIAGNOSIS; HUMAN; IMMUNOGLOBULIN G4 RELATED DISEASE; REGULATORY T LYMPHOCYTE; REVIEW;

EID: 84992756657     PISSN: 20903448     EISSN: 20903456     Source Type: Journal    
DOI: 10.1155/2014/803876     Document Type: Review

References (56)

1. M. Shiokawa, Y. Kodama, K. Yoshimura et al., "Risk of cancer in patients with autoimmune pancreatitis," American Journal of Gastroenterology, vol. 108, no. 4, pp. 610-617, 2013.
2. B. K. Straub, I. Esposito, D. Gotthardt et al., "IgG4-associated cholangitis with cholangiocarcinoma," Virchows Archiv, vol. 458, no. 6, pp. 761-765, 2011.
3. C. H. Oh, J. G. Kim, J. W. Kim et al., "Early bile duct cancer in a background of sclerosing cholangitis and autoimmune pancreatitis," Internal Medicine, vol. 47, no. 23, pp. 2025-2028, 2008.
4. H. Hamano, S. Kawa, A. Horiuchi et al., "High serum IgG4 concentrations in patients with sclerosing pancreatitis," The New England Journal of Medicine, vol. 344, no. 10, pp. 732-738, 2001.
5. H. Hamano, S. Kawa, Y. Ochi et al., "Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis," The Lancet, vol. 359, no. 9315, pp. 1403-1404, 2002.
6. Y. Zen and Y. Nakanuma, "IgG4-related disease: a crosssectional study of 114 cases," American Journal of Surgical Pathology, vol. 34, no. 12, pp. 1812-1819, 2010.
7. M. Koyabu, K. Uchida, N. Fukata et al., "Primary sclerosing cholangitis with elevated serum IgG4 levels and/or infiltration of abundant IgG4-positive plasma cells," Journal of Gastroenterology, vol. 45, no. 1, pp. 122-129, 2010.
8. Y. Zen, A. Quaglia, and B. Portmann, "Immunoglobulin G4-positive plasma cell infiltration in explanted livers for primary sclerosing cholangitis," Histopathology, vol. 58, no. 3, pp. 414-422, 2011.
9. A. Raina, A. M. Krasinskas, J. B. Greer et al., "Serum immunoglobulin G fraction 4 levels in pancreatic cancer: elevations not associated with autoimmune pancreatitis," Archives of Pathology & Laboratory Medicine, vol. 132, no. 1, pp. 48-53, 2008.
10. A. Ghazale, S. T. Chari, T. C. Smyrk et al., "Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer," American Journal of Gastroenterology, vol. 102, no. 8, pp. 1646-1653, 2007.
11. T. Kamisawa, P. Y. Chen, Y. Tu et al., "Pancreatic cancer with a high serum IgG4 concentration," World Journal of Gastroenterology, vol. 12, no. 38, pp. 6225-6228, 2006.
12. D. Dhall, A. A. Suriawinata, L. H. Tang, J. Shia, and D. S. Klimstra, "Use of immunohistochemistry for IgG4 in the distinction of autoimmune pancreatitis from peritumoral pancreatitis," Human Pathology, vol. 41, no. 5, pp. 643-652, 2010.
13. M. D. Leise, T. C. Smyrk, N. Takahashi, S. R. Sweetser, S. S. Vege, and S. T. Chari, "IgG4-associated cholecystitis: another clue in the diagnosis of autoimmune pancreatitis," Digestive Diseases and Sciences, vol. 56, no. 5, pp. 1290-1294, 2011.
14. S. C. Abraham, M. Cruz-Correa, P. Argani, E. E. Furth, R. H. Hruban, and J. K. Boitnott, "Lymphoplasmacytic chronic cholecystitis and biliary tract disease in patients with lymphoplasmacytic sclerosing pancreatitis," The American Journal of Surgical Pathology, vol. 27, no. 4, pp. 441-451, 2003.
15. T. Kamisawa, Y. Tu, H. Nakajima et al., "Sclerosing cholecystitis associated with autoimmune pancreatitis," World Journal of Gastroenterology, vol. 12, no. 23, pp. 3736-3739, 2006.
16. H. Ohara, K. Okazaki, H. Tsubouchi et al., "Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012," Journal of Hepato-Biliary-Pancreatic Sciences, vol. 19, no. 5, pp. 536-542, 2012.
17. Y. J. Resheq, A. Quaas, D. von Renteln, C. Schramm, A. W. Lohse, and S. Lüth, "Infiltration of peritumoural but tumourfree parenchyma with IgG4-positive plasma cells in hilar cholangiocarcinoma and pancreatic adenocarcinoma," Digestive and Liver Disease, vol. 45, no. 10, pp. 859-865, 2013.
18. U. Motosugi, T. Ichikawa, H. Yamaguchi et al., "Small invasive ductal adenocarcinoma of the pancreas associated with lymphoplasmacytic sclerosing pancreatitis: case Report," Pathology International, vol. 59, no. 10, pp. 744-747, 2009.
19. + regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions," Clinical Cancer Research, vol. 12, no. 18, pp. 5423-5434, 2006.
20. 3 cell ratio is a predictive marker for survival in patients with colorectal cancer," Cancer Immunology, Immunotherapy, vol. 59, no. 5, pp. 653-661, 2010.
21. H. Miyoshi, K. Uchida, T. Taniguchi et al., "Circulating naïve and CD4+CD25high regulatory T cells in patients with autoimmune pancreatitis," Pancreas, vol. 36, no. 2, pp. 133-140, 2008.
22. M. Koyabu, K. Uchida, H. Miyoshi et al., "Analysis of regulatory T cells and IgG4-positive plasma cells among patients of IgG4-related sclerosing cholangitis and autoimmune liver diseases," Journal of Gastroenterology, vol. 45, no. 7, pp. 732-741, 2010.
23. T. Kusuda, K. Uchida, H. Miyoshi et al., "Involvement of inducible costimulator- and interleukin 10-positive regulatory T cells in the development of IgG4-related autoimmune pancreatitis," Pancreas, vol. 40, no. 7, pp. 1120-1130, 2011.
24. Y. Fukui, K. Uchida, K. Sumimoto et al., "Thesimilarity of Type 1 autoimmune pancreatitis to pancreatic ductal adenocarcinoma with significant IgG4-positive plasma cell infiltration," Journal of Gastroenterology, vol. 48, no. 6, pp. 751-761, 2013.
25. Y. Zen, T. Fujii, K. Harada et al., "Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis," Hepatology, vol. 45, no. 6, pp. 1538-1546, 2007.
26. - intra-epithelial lymphocytes are increased in primary biliary cirrhosis," Pathology International, vol. 56, no. 1, pp. 17-24, 2006.
27. Y. Kimura, K. Harada, and Y. Nakanuma, "Pathologic significance of immunoglobulin G4-positive plasma cells in extrahepatic cholangiocarcinoma," Human Pathology, vol. 43, no. 12, pp. 2149-2156, 2012.
28. P. Jeannin, S. Lecoanet, Y. Delneste, J. F. Gauchat, and J. Y. Bonnefoy, "IgE versus IgG4 production can be differentially regulated by IL-10," Journal of Immunology, vol. 160, no. 7, pp. 3555-3561, 1998.
29. D. S. Robinson, M. Larché, and S. R. Durham, "Tregs and allergic disease," The Journal of Clinical Investigation, vol. 114, no. 10, pp. 1389-1397, 2004.
30. S. Hinz, L. Pagerols-Raluy, H. Oberg et al., "Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer," Cancer Research, vol. 67, no. 17, pp. 8344-8350, 2007.
31. W. H. Wang, C. L. Jiang, W. Yan et al., "FOXP3 expression and clinical characteristics of hepatocellular carcinoma," World Journal of Gastroenterology, vol. 16, no. 43, pp. 5502-5509, 2010.
32. L. M. Ebert, B. S. Tan, J. Browning et al., "The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells," Cancer Research, vol. 68, no. 8, pp. 3001-3009, 2008.
33. V. Karanikas, M. Speletas, M. Zamanakou et al., "Foxp3 expression in human cancer cells," Journal of Translational Medicine, vol. 6, article 19, 2008.
34. M. Battaglia, C. Gianfrani, S. Gregori, and M. G. Roncarolo, "IL-10-producing T regulatory type 1 cells and oral tolerance," Annals of the New York Academy of Sciences, vol. 1029, pp. 142-153, 2004.
35. S. Shimoda, F. Ishikawa, T. Kamihira et al., "Autoreactive Tcell responses in primary biliary cirrhosis are proinflammatory whereas those of controls are regulatory," Gastroenterology, vol. 131, no. 2, pp. 606-618, 2006.
36. V. Bal, A. McIndoe, G. Denton et al., "Antigen presentation by keratinocytes induces tolerance in human T cells," European Journal of Immunology, vol. 20, no. 9, pp. 1893-1897, 1990.
37. J. Markmann, D. Lo, A. Naji, R.D. Palmiter, R. L. Brinster, and E. Heber-Katz, "Antigen presenting function of class II MHC expressing pancreatic beta cells," Nature, vol. 336, no. 6198, pp. 476-479, 1988.
38. G. Lombardi, K. Arnold, J. Uren et al., "Antigen presentation by interferon-γ-treated thyroid follicular cells inhibits interleukin- 2 (IL-2) and supports IL-4 production by B7-dependent human T cells," European Journal of Immunology, vol. 27, no. 1, pp. 62-71, 1997.
39. H. Inoue, H. Miyatani, Y. Sawada, and Y. Yoshida, "A case of pancreas cancer with autoimmune pancreatitis," Pancreas, vol. 33, no. 2, pp. 208-209, 2006.
40. M. Loos, I. Esposito, D. M. Hedderich et al., "Autoimmune pancreatitis complicated by carcinoma of the pancreatobiliary system: a case report and review of the literature," Pancreas, vol. 40, no. 1, pp. 151-154, 2011.
41. R. Pezzilli, S. Vecchiarelli, M. C. Di Marco et al., "Pancreatic ductal adenocarcinoma associated with autoimmune pancreatitis," Case Reports in Gastroenterology, vol. 5, no. 2, pp. 378-385, 2011.
42. M. Yamamoto, H. Takahashi, T. Tabeya et al., "Riskofmalignancies in IgG4-related disease," Modern Rheumatology, vol. 22, no. 3, pp. 414-418, 2012.
43. K. Hirano, M. Tada, N. Sasahira et al., "Incidence of malignancies in patients with IgG4-related disease," Internal Medicine, vol. 53, no. 3, pp. 171-176, 2014.
44. F. Mendes and K. D. Lindor, "Primary sclerosing cholangitis: overview and update," Nature Reviews Gastroenterology and Hepatology, vol. 7, no. 11, pp. 611-619, 2010.
45. A. Tanaka, S. Tazuma, K. Okazaki, H. Tsubouchi, K. Inui, and H. Takikawa, "Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan," Journal of Hepato-Biliary-Pancreatic Sciences, vol. 21, no. 1, pp. 43-50, 2014.
46. H. Ohtani, H. Ishida, Y. Ito, T. Yamaguchi, and M. Koizumi, "Autoimmune pancreatitis and biliary intraepithelial neoplasia of the common bile duct: a case with diagnostically challenging but pathogenetically significant association," Pathology International, vol. 61, no. 8, pp. 481-485, 2011.
47. Y. Nakanuma, M.-P. Curado, S. Franceschi et al., "Intrahepatic cholangiocarcinoma," in WHO Classification of Tumors of the Digestive System; World Health Organization of Tumors, F. T. Bosman, F. Carneiro, R. H. Hruban, and N. D. Theise, Eds., pp. 217-224, IARC, Lyon, France, 2010.
48. M. Takeuchi, Y. Sato, K. Ohno et al., "T helper 2 and regulatory T-cell cytokine production by mast cells: a key factor in the pathogenesis of IgG4-related disease," Modern Pathology, 2014.
49. T. Tanikawa, C. M. Wilke, I. Kryczek et al., "Interleukin-10 ablation promotes tumor development, growth, andmetastasis," Cancer Research, vol. 72, no. 2, pp. 420-429, 2012.
50. K. Harada and Y. Nakanuma, "Pathological differences between IgG4-related sclerosing cholangitis with and without autoimmune pancreatitis (the 102nd USCAP annual meeting abstracts)," Modern Pathology, vol. 26, supplement 2, p. 403A, 2013.
51. H. Hamano, S. Kawa, T. Uehara et al., "Immunoglobulin G4-related lymphoplasmacytic sclerosing cholangitis that mimics infiltrating hilar cholangiocarcinoma: part of a spectrum of autoimmune pancreatitis?" Gastrointestinal Endoscopy, vol. 62, no. 1, pp. 152-157, 2005.
52. H. Umehara, K. Okazaki, Y. Masaki et al., "Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011," Modern Rheumatology, vol. 22, no. 1, pp. 21-30, 2012.
53. A. Ghazale, S. T. Chari, L. Zhang et al., "Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy," Gastroenterology, vol. 134, no. 3, pp. 706-715, 2008.
54. S. T. Chari, T. C. Smyrk, M. J. Levy et al., "Diagnosis of autoimmune pancreatitis: the mayo clinic experience," Clinical Gastroenterology and Hepatology, vol. 4, no. 8, pp. 1010-1016, 2006.
55. H. Kawakami, Y. Zen, M. Kuwatani et al., "IgG4-related sclerosing cholangitis and autoimmune pancreatitis: histological assessment of biopsies from Vater's ampulla and the bile duct," Journal of Gastroenterology and Hepatology, vol. 25, no. 10, pp. 1648-1655, 2010.
56. T. Umemura, Y. Zen, H. Hamano, S. Kawa, Y. Nakanuma, and K. Kiyosawa, "Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis," Hepatology, vol. 46, no. 2, pp. 463-471, 2007.